| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |